21.29
21.29 (0%)
As of Apr 17, 2025
Vera Therapeutics, Inc. [VERA]
Source:
Company Overview
Vera Therapeutics, Inc. is a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases.
| Country | United States |
| Headquarters | brisbane, california |
| Phone Number | (650) 770-0077 |
| Industry | manufacturing |
| CEO | Marshall Fordyce, M.D. |
| Website | www.veratx.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-167.2 |
| Net Income | $-152.1 |
| Net Cash | $47 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -36.6% |
| Profit as % of Stockholder Equity | -26.4% |
Management Effectiveness
| Return on Equity | -26.4% |
| Return on Assets | -23.2% |
| Turnover Ratio | |
| EBITA | $-167.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $655.7 |
| Total Liabilities | $78.5 |
| Operating Cash Flow | $-134.7 |
| Investing Cash Flow | $-425 |
| Financing Cash Flow | $606.7 |
